or Try an Advanced Search...

    Technical Analysis for PRQR - ProQR Therapeutics B.V.

    Grade Last Price % Change Price Change
    F 1.65 -0.60% -0.01
    PRQR closed down 0.6 percent on Monday, July 1, 2024, on 36 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PRQR trend table...
    Date Alert Name Type % Chg
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -0.60%
    Oversold Stochastic Weakness -0.60%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Shooting Star Candlestick Bearish -0.60%
    Doji - Bearish? Reversal -0.60%
    Oversold Stochastic Weakness -0.60%
    Older End-of-Day Signals for PRQR ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    10 DMA Resistance about 9 hours ago
    Up 3% about 9 hours ago
    Down 1% about 9 hours ago
    Up 2% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PRQR Chart by TradingView
    Basic chart:

    Profile

    ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Genetic Disorder Therapeutic Gene Modulation Treatment Of Cystic Fibrosis

    Is PRQR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 23 Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company
    Jun 18 ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit
    May 13 Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago
    May 11 ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript)
    May 9 ProQR GAAP EPS of -€0.09, revenue of €4.45M
    May 9 ProQR Announces First Quarter 2024 Operating and Financial Results
    May 8 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases
    Apr 23 ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
    Apr 22 ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
    Apr 19 ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
    See more PRQR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.29
    52 Week Low 1.11
    Average Volume 106,604
    200-Day Moving Average 1.84
    50-Day Moving Average 1.88
    20-Day Moving Average 1.78
    10-Day Moving Average 1.67
    Average True Range 0.10
    RSI (14) 31.97
    ADX 20.36
    +DI 14.36
    -DI 21.00
    Chandelier Exit (Long, 3 ATRs) 1.81
    Chandelier Exit (Short, 3 ATRs) 1.90
    Upper Bollinger Bands 2.03
    Lower Bollinger Band 1.52
    Percent B (%b) 0.25
    BandWidth 28.49
    MACD Line -0.08
    MACD Signal Line -0.07
    MACD Histogram -0.0052
    Fundamentals Value
    Market Cap 133.91 Million
    Num Shares 81.2 Million
    EPS -0.51
    Price-to-Earnings (P/E) Ratio -3.24
    Price-to-Sales 36.79
    Price-to-Book 3.58
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.78
    Resistance 3 (R3) 1.79 1.75 1.76
    Resistance 2 (R2) 1.75 1.72 1.75 1.75
    Resistance 1 (R1) 1.70 1.70 1.73 1.69 1.74
    Pivot Point 1.67 1.67 1.68 1.66 1.67
    Support 1 (S1) 1.62 1.63 1.64 1.61 1.56
    Support 2 (S2) 1.58 1.61 1.58 1.55
    Support 3 (S3) 1.53 1.58 1.54
    Support 4 (S4) 1.52